Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

AMPICILLIN AND SULBACTAM

AMPICILLIN SODIUM; SULBACTAM SODIUM

Standard Dose
EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview AMPICILLIN AND SULBACTAM is listed in Drugs@FDA under application 201406 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient AMPICILLIN SODIUM; SULBACTAM SODIUM Form and strength INJECTABLE;INJECTION - EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL Sponsor ANTIBIOTICE Submission history Latest submission status date: 2024-09-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMPICILLIN AND SULBACTAM is listed in Drugs@FDA under application 201406 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient AMPICILLIN SODIUM; SULBACTAM SODIUM Form and strength INJECTABLE;INJECTION - EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL Sponsor ANTIBIOTICE Submission history Latest submission status date: 2024-09-27 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM; SULBACTAM SODIUM) | Drug Monograph | MedicHelpline